Delcath Systems Files Q2 2024 10-Q
Ticker: DCTH · Form: 10-Q · Filed: Aug 5, 2024 · CIK: 872912
Sentiment: neutral
Topics: 10-Q, SEC Filing, Financials
TL;DR
DELCATH SYSTEMS 10-Q FILED: Q2 2024 RESULTS ARE IN.
AI Summary
Delcath Systems, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second quarter of 2024. Key financial figures and business developments are presented within this report.
Why It Matters
This filing provides investors with the latest financial health and operational status of Delcath Systems, Inc., crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — As a publicly traded company filing a 10-Q, Delcath Systems is subject to market and operational risks inherent in the healthcare sector.
Key Players & Entities
- DELCATH SYSTEMS, INC. (company) — Filer of the 10-Q
- 20240630 (date) — End of reporting period
- 20240805 (date) — Filing date
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended June 30, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on August 5, 2024.
What is the company's Standard Industrial Classification code?
The company's Standard Industrial Classification code is 3841, for Surgical & Medical Instruments & Apparatus.
Where is Delcath Systems, Inc. headquartered?
Delcath Systems, Inc. is located at 566 Queensbury Avenue, Queensbury, NY 12804.
What is the fiscal year end for Delcath Systems, Inc.?
The fiscal year end for Delcath Systems, Inc. is December 31.
Filing Stats: 4,741 words · 19 min read · ~16 pages · Grade level 18 · Accepted 2024-08-05 16:36:10
Key Financial Figures
- $0.01 — ange on which registered Common stock, $0.01 par value per share DCTH The Nasdaq Cap
- $0.1 million — s of June 30, 2024, there was less than $0.1 million of interest receivable related to the o
Filing Documents
- dcth-20240630.htm (10-Q) — 1031KB
- delcath-lscmagreementxamen.htm (EX-10.1) — 22KB
- dcth-20240630xexx311.htm (EX-31.1) — 10KB
- dcth-20240630xexx312.htm (EX-31.2) — 10KB
- dcth-20240630xexx321.htm (EX-32.1) — 5KB
- dcth-20240630xexx322.htm (EX-32.2) — 5KB
- 0001628280-24-034769.txt ( ) — 7193KB
- dcth-20240630.xsd (EX-101.SCH) — 67KB
- dcth-20240630_cal.xml (EX-101.CAL) — 71KB
- dcth-20240630_def.xml (EX-101.DEF) — 275KB
- dcth-20240630_lab.xml (EX-101.LAB) — 662KB
- dcth-20240630_pre.xml (EX-101.PRE) — 471KB
- dcth-20240630_htm.xml (XML) — 1002KB
—FINANCIAL INFORMATION
PART I—FINANCIAL INFORMATION Item 1.
Financial Statements
Financial Statements Unaudited Condensed Consolidated Balance Sheets as of Ju ne 30 , 2024 and December 31, 2023 3 Unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss for the three an d six months ended June 30 , 2024 and 2023 4 Unaudited Condensed Consolidated Statements of Stockholders' Equity (Deficit) for the three and six months ended Ju ne 30 , 2024 and 2023 5 Unaudited Condensed Consolidated Statements of Cash Flows for the six months ended June 30 , 2024 and 2023 7 Notes to the Condensed Consolidated Financial Statements 9 Item 2.
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations 25 Item 3.
Quantitative and Qualitative Disclosures About Market Risk
Quantitative and Qualitative Disclosures About Market Risk 30 Item 4.
Controls and Procedures
Controls and Procedures 30
—OTHER INFORMATION
PART II—OTHER INFORMATION 31 Item 1 .
Legal Proceedings
Legal Proceedings 31 Item 1A.
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 31
Defaults Upon Senior Securities
Item 3. Defaults Upon Senior Securities 31
Mine Safety Disclosure
Item 4. Mine Safety Disclosure 31
Other Information
Item 5. Other Information 31 Item 6. Exhibits 32
SIGNATURES
SIGNATURES 34 2 Table of Contents DELCATH SYSTEMS, INC. Condensed Consolidated Balance Sheets (Unaudited) (in thousands, except share and per share data) June 30, 2024 December 31, 2023 Assets Current assets Cash and cash equivalents $ 14,782 $ 12,646 Restricted cash — 50 Short-term investments 5,124 19,808 Accounts receivable, net 3,726 241 Inventory 6,316 3,322 Prepaid expenses and other current assets 1,451 1,091 Total current assets 31,399 37,158 Property, plant and equipment, net 1,422 1,352 Right-of-use assets 1,092 103 Total assets $ 33,913 $ 38,613 Liabilities and Stockholders' Equity Current liabilities Accounts payable $ 3,279 $ 1,012 Accrued expenses 4,418 5,249 Lease liabilities, current 103 37 Loan payable — 5,239 Convertible notes payable 4,491 4,911 Total current liabilities 12,291 16,448 Warrant liability 15,809 5,548 Lease Liabilities, non-current 989 — Other liabilities, non-current 632 840 Total liabilities 29,721 22,836 Commitments and contingencies (see Note 14) Stockholders' equity Preferred stock, $ 0.01 par value; 10,000,000 shares authorized; 12,342 and 24,819 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively — — Common stock, $ 0.01 par value; 80,000,000 shares authorized; 27,931,393 shares and 22,761,554 shares issued and outstanding at June 30, 2024 and December 31, 2023, respectively 279 228 Additional paid-in capital 533,919 520,576 Accumulated deficit ( 530,014 ) ( 505,162 ) Accumulated other comprehensive loss 8 135 Total stockholders' equity 4,192 15,777 Total liabilities and stockholders' equity $ 33,913 $ 38,613 See accompanying Notes to Unaudited Condensed Consolidated Financial Statements. 3 Table of Contents DELCATH SYSTEMS, INC. Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) (in thousands, except share and per share data) Three months ended June 30, Six months ended June 30, 2024 2023 2024 2023 Produ